SCHEMBL24720992

SCHEMBL24720992

CC(C)c1cccc(-c2ccc(C(F)(F)F)c(C(F)(F)F)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 4/20 0.52
RXRA P19793 2/20 0.49
RXRB P28702 2/20 0.49
RXRG P48443 2/20 0.49
AR P10275 3/20 0.42
PGR P06401 1/20 0.39
KIF11 P52732 1/20 0.39
NOTUM Q6P988 1/20 0.38
CYP11B2 P19099 1/20 0.38
HSD17B1 P14061 2/20 0.36
HSD17B2 P37059 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MDM4 O15151 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
TYR P14679 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24721248 0.87 KIF11 (0.56) PTPN5RXRARXRBRXRGKIF11
SCHEMBL22699905 0.87 PTPN5 (0.50) PTPN5RXRARXRBRXRGAR
SCHEMBL24720989 0.85 PTPN5 (0.49) PTPN5RXRARXRBRXRGAKR1C3
SCHEMBL24721371 0.83 PTPN5 (0.47) PTPN5RXRARXRBRXRGAR
SCHEMBL18878437 0.81 PTPN5 (0.66) PTPN5RXRARXRBRXRGKIF11
SCHEMBL13304198 0.79 LMNA (0.40) PTPN5KIF11NOTUMALDH1A1TYR
SCHEMBL5352034 0.79 RXRA (0.62) PTPN5RXRARXRBRXRGKDM4E
SCHEMBL2662570 0.79 PTPN5 (0.65) PTPN5RXRARXRBRXRGKIF11
SCHEMBL15340840 0.78 PTPN5 (0.49) PTPN5ARAKR1C3AKR1C2
SCHEMBL598181 0.77 RXRA (0.66) PTPN5RXRARXRBRXRGHSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220324866-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2022-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220324866-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS DGKG, DGKB, DGKK PTPN5 2223/4885RXRA 1414/4885RXRB 1016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.